What is required for the storage of refrigerated antineoplastic HDs?

For the storage of refrigerated antineoplastic hazardous drugs (HDs), it is essential that these medications are kept in a dedicated refrigerator located in a negative pressure area. This requirement ensures that any potential contamination is contained, protecting both staff and patients from exposure to these hazardous substances.

A dedicated refrigerator minimizes the risk of cross-contamination with non-hazardous materials and medications. The negative pressure environment further enhances safety by ensuring that air from the surrounding area does not flow into the space where the hazardous drugs are being stored, thus containing any airborne particles that may arise.

Implementing these stringent storage requirements is crucial to comply with USP 800, which outlines practices to protect personnel, patients, and the environment when handling hazardous drugs. Therefore, the storage of refrigerated antineoplastic HDs must adhere to these guidelines to ensure maximum safety and compliance.